glp 1 aspiration risk Your patient took semaglutide this week. Cancel the EGD, proceed, or risk-stratify? The OCULUS randomized trial found clinically significant residual gastric volume was higher when GLP-1/GIP agonists were continued vs held for Benefit-Risk Assessment of GLP-1 Receptor
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14



















:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)



